Steve Gillis
Managing Director
Seattle, Washington, United States
72 investmentsSteve Gillis is a Managing Director based in Seattle, Washington, United States. Steve Gillis has backed 72 companies, including KSQ Therapeutics, OncoResponse and Remix Therapeutics. Investment focus areas include Health Care, Medical Testing and Enterprise Software.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Portfolio Companies (72)
| Industry | Stage | Website | |||
|---|---|---|---|---|---|
| 1 | KSQ Therapeutics | — | — | — | — |
| 2 | OncoResponse | — | — | — | — |
| 3 | Remix Therapeutics | — | — | — | — |
| 4 | LifeMine Therapeutics | — | — | — | — |
| 5 | Cero Therapeutics | — | — | — | — |
| 6 | Encoded Therapeutics | — | — | — | — |
| 7 | Locanabio | — | — | — | — |
| 8 | Faraday Pharmaceuticals | — | — | — | — |
| 9 | AgBiome | — | — | — | — |
| 10 | Metacrine | — | — | — | — |
| 11 | One BioMed | — | — | — | — |
| 12 | Theraclone Sciences | — | — | — | — |
Showing 1–12 of 72
Page 1 of 6
Access Full Contact Information
Get Steve Gillis's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
No credit card required
Raising a round? Run your numbers first
Free tools founders use before pitching investors like this one.